Journal of Drugs in Dermatology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q3 | 50.5% | 0.623 | Q2 | 69.0% |
| 2024 | 1.8 | Q3 | 42.7% | 0.624 | Q2 | 69.7% |
| 2023 | 1.5 | Q3 | 36.6% | 0.637 | Q2 | 72.7% |
| 2022 | 1.5 | Q4 | 33.3% | 0.648 | Q2 | 74.4% |
| 2021 | 1.6 | Q4 | 44.1% | 0.618 | Q2 | 73.7% |
| 2020 | — | — | 0.701 | Q2 | 76.2% | |
| 2019 | — | — | 0.563 | Q2 | 70.8% | |
| 2018 | — | — | 0.723 | Q2 | 75.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1545-9616
country
UScoverage
2002-2026